Dabur Pharma subsidiary receives ANDA Approval for Peclitaxel Molecule

Dabur Pharma Ltd has announced that the Company's Wholly Owned Subsidiary at United Kingdom, Dabur Oncology Plc. has been granted ANDA approval for its Paclitaxel molecule by USA FDA on November 27, 2006.

Source : Equity Bulls

Keywords